Company Filing History:
Years Active: 2017
Title: Omprakash Reddy Iguturi: Innovator in Cancer Treatment
Introduction
Omprakash Reddy Iguturi is a notable inventor based in Guntur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for cancer treatment. His work exemplifies the intersection of science and innovation, aiming to improve patient outcomes.
Latest Patents
Omprakash Reddy Iguturi holds a patent for Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors. This patent discloses compounds of Formula (IIa), wherein R, R, R, R, R, R, R, and R are defined in the specification, along with pharmaceutically acceptable salts thereof. These compounds may be utilized as agents in the treatment of various diseases, including cancer. Additionally, the patent provides pharmaceutical compositions comprising one or more compounds of Formula (IIa).
Career Highlights
Omprakash is currently employed at AbbVie Inc., where he continues to advance his research and development efforts. His work at AbbVie has allowed him to focus on creating innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Yunsong Tong and Milan Bruncko. Their collaborative efforts contribute to the dynamic research environment at AbbVie, fostering innovation and the development of new therapeutic agents.
Conclusion
Omprakash Reddy Iguturi is a dedicated inventor whose work in developing cancer treatment compounds showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his innovative spirit continues to inspire others in the field.